Go to Homepage

United States

|

Pursuing clinical breakthroughs that transform lives

A proud history of delivering high‑quality treatments that continues today

At Merz Therapeutics, we are developing innovative medicines to improve patient outcomes. We’re focused on specialty neurology, where we are best placed to make the most difference.

Our pipeline at a glance

This table overviews our late-stage clinical development programs for XEOMIN® (incobotulinumtoxinA) and is updated regularly.
Last updated: March 2026 

FILTER BY STATUS

Phase 1

Phase 2

Phase 3

Approval

Indication

Lower Limb Spasticity

Therapeutic Area

Neurology / Movement Disorders

Product

NT 201

Phase 3

Indication

Lower Limb Pediatric Spasticity

Therapeutic Area

Neurology / Movement Disorders

Product

NT 201

Phase 3

Indication

Migraine

Therapeutic Area

Pain Management

Product

NT 201

Phase 3

Indication

Peripheral Neuropathic Pain

Therapeutic Area

Pain Management

Product

NT 201

Phase 2

You might also like

Contact Icon

U.S. General Inquiries

919-582-8000 merztherapeutics@merz.com

U.S. Human Resources

merztherapeutics@merz.com

U.S. Customer service

1-855-463-7989 therapeuticorders@merz.com

Global Corporate development

Platform change – You are leaving this page.

You are leaving this website. With respect to the content of the following page, as well as to links to other websites located on this page, Merz Therapeutics U.S. has no way of controlling the content of these sites. Merz Therapeutics U.S. assumes no responsibility for the content of these sites or the consequences of their use by visitors. However, we ask you to notify us immediately of any illegal content on the linked sites.

Continue to url

Change of country – You are leaving this page.

You are leaving this website. The content of the following sites maintained by the parent company or another affiliated company, or links to other sites located on this site, is subject to the legal requirements of the country in which the site is maintained. Merz Therapeutics U.S. accepts no responsibility whatsoever for the content of these websites or for the consequences of their use by visitors. However, we ask you to notify us immediately of any illegal content on the linked sites.

Continue to url